Oral Research Presentations: Session 1: Antiretroviral Therapy
Abstract O1: Safety of switching raltegravir 400mg twice daily to raltegravir 800mg once daily in virologically suppressed patients
Miss Amy Moore, Chelsea and Westminster Hospital NHS Foundation Trust, London
Click here to go back to all presentations.